Patton Albertson Miller Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,411
| Closed | -$2.28M | – | 245 |
|
|
2021
Q2 | $2.28M | Sell |
12,411
-18
| -0.1% | -$3.31K | 0.52% | 70 |
|
|
2021
Q1 | $1.9M | Buy |
12,429
+365
| +3% | +$55.8K | 0.46% | 72 |
|
|
2020
Q4 | $1.89M | Buy |
12,064
+294
| +2% | +$46.1K | 0.45% | 73 |
|
|
2020
Q3 | $1.35M | Sell |
11,770
-524
| -4% | -$60K | 0.38% | 79 |
|
|
2020
Q2 | $1.38M | Buy |
12,294
+360
| +3% | +$40.4K | 0.4% | 80 |
|
|
2020
Q1 | $1.07M | Buy |
11,934
+3,191
| +36% | +$287K | 0.36% | 91 |
|
|
2019
Q4 | $946K | Sell |
8,743
-4,443
| -34% | -$481K | 0.25% | 112 |
|
|
2019
Q3 | $1.29M | Buy |
13,186
+1,154
| +10% | +$113K | 0.37% | 96 |
|
|
2019
Q2 | $1.32M | Buy |
+12,032
| New | +$1.32M | 0.38% | 90 |
|